CLINICAL ROLE -
Opinion
Video
Author(s):
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Study Reports Dietary Recommendation for Managing GLP-1-Related Gastrointestinal Adverse Events
FDA Approves Mirikizumab-Mrkz to Treat Adult Patients With Crohn Disease
Prucalopride Tablets for Chronic Idiopathic Constipation Launches, Approved for 180-Day CGT Designation
Optimizing Inflammatory Bowel Disease Management: The Value of Integrated Pharmacists in Modern Health Care
Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease
Are OTC Proton Pump Inhibitors a Boon Or a Curse?